Skip to main content

Featured

Ukrainian Strike Targets Key Russian Missile Facility in Deep-Range Operation

    An employee controls an unmanned ground vehicle during an exhibition of Ukrainian drone makers, amid Russia's attack on Ukraine, in an undisclosed location Ukraine says it carried out a long‑range strike against a major Russian ballistic missile production site, marking one of Kyiv’s deepest attacks inside Russian territory since the full‑scale invasion began. According to Ukrainian security officials, the operation targeted a facility involved in manufacturing components for Russia’s Iskander missile systems—munitions frequently used against Ukrainian cities. While Moscow has not confirmed the strike, Russian regional authorities reported explosions and a subsequent fire at an industrial site. Kyiv has increasingly relied on domestically produced long‑range drones and missiles as Western military aid faces delays, and Ukrainian officials framed the attack as part of a broader effort to degrade Russia’s ability to wage war. The strike underscores Ukraine’s evolving stra...
Post a Comment
Read more

article

Labels

Stock Futures Steady as Investors Await Fresh Jobs Data

U.S. stock futures were little changed on Thursday as Wall Street attempted to recover from recent declines. Futures tied to the S&P 500 were flat, while Nasdaq futures rose slightly. Dow Jones Industrial Average futures fell marginally.

Labor Market Update: Today’s spotlight is on the release of the report on initial weekly jobless claims. A positive number could reassure traders about the state of the jobs market, while a negative one may introduce more turbulence. Last week’s sluggish non-farm payrolls update was one of the catalysts for recent declines.

Individual Movers:

  • Nvidia (NVDA): The AI giant’s stock is in focus after a back-and-forth day left it down another 5%.
  • Eli Lilly (LLY): The company’s stock soared over 10% in premarket trading after boosting its annual revenue and profit forecasts on strong weight-loss drug sales.


Labels:

Comments

Post a Comment